Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics

被引:77
作者
Turgeon, D [1 ]
Carrier, JS [1 ]
Chouinard, S [1 ]
Bélanger, A [1 ]
机构
[1] CHU Laval, Res Ctr, Oncol & Mol Endocrinol Res Ctr, Quebec City, PQ G1V 4G2, Canada
关键词
D O I
10.1124/dmd.31.5.670
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferase (UGT) 2B17 is one of the most important conjugating enzymes in androgen metabolism and shares more than 95% homology with UGT2B15. Although UGT2B15 has been fully characterized for its ability to conjugate drugs, environmental pollutants, and dietary components, UGT2B17 received less attention for its capacity to glucuronidate xenobiotics. In the present study, more than 55 exogenous compounds belonging to several categories of compounds were analyzed as potential substrates for UGT2B17. Glucuronidation activity was observed with several coumarins, anthraquinones, and flavonoids. The higher glucuronidation activity was measured with alizarin ( 125 pmol . min(-1). mg protein(-1)), whereas UGT2B17 conjugated eugenol, scopoletin, and galangin with glucuronidation rates of 102.5, 102, and 58 pmol . min(-1) . mg protein(-1), respectively. The characterization of UGT2B17 as a xenobiotics- conjugating enzyme demonstrates that its role is not limited to androgen metabolism and that its specificity for exogenous substrates is different from other UGT2B isoforms. Taken together, these data suggest a role of UGT2B17 for the hepatic detoxification.
引用
收藏
页码:670 / 676
页数:7
相关论文
共 39 条
[1]   Protection by the flavonoids myricetin, quercetin, and rutin against hydrogen peroxide-induced DNA damage in Caco-2 and Hep G2 cells [J].
Aherne, SA ;
O'Brien, NM .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1999, 34 (02) :160-166
[2]   The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes [J].
Albert, C ;
Vallée, M ;
Beaudry, G ;
Bélanger, A ;
Hum, DW .
ENDOCRINOLOGY, 1999, 140 (07) :3292-3302
[3]  
Barbier O, 2000, DRUG METAB DISPOS, V28, P497
[4]   Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C-19 steroids [J].
Beaulieu, M ;
Levesque, E ;
Hum, DW ;
Belanger, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22855-22862
[5]   Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11 [J].
Beaulieu, M ;
Lévesque, E ;
Hum, DW ;
Bélanger, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (01) :44-50
[6]  
BUENING MK, 1981, CANCER RES, V41, P67
[7]   CHARACTERIZATION OF A CLONED HUMAN DIHYDROTESTOSTERONE ANDROSTANEDIOL UDP-GLUCURONOSYLTRANSFERASE AND ITS COMPARISON TO OTHER STEROID ISOFORMS [J].
CHEN, F ;
RITTER, JK ;
WANG, MG ;
MCBRIDE, OW ;
LUBET, RA ;
OWENS, IS .
BIOCHEMISTRY, 1993, 32 (40) :10648-10657
[8]  
Coffman BL, 1997, DRUG METAB DISPOS, V25, P1
[9]  
Coffman BL, 1998, DRUG METAB DISPOS, V26, P73
[10]   UDP glucuronosyltransferase mRNA levels in human liver disease [J].
Congiu, M ;
Mashford, ML ;
Slavin, JL ;
Desmond, PV .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (02) :129-134